9 In the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX Access) trial, there was a borderline significant reduction in all-cause mortality with the use of transradial access, regardless of ACS type. 10 For the population of patients presenting with STEMI, transradial access is now recommended as a Class I level of evidence A recommendation in the European Society of Cardiology (ESC) guidelines 11 if performed by an experienced radial operator.
← all excerpts
Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for ST-Elevation Myocardial Infarction and Non-St-Elevation Acute Coronary Syndrome.
1
—
—